Company news
Genetic Technologies Limited news in 2024
Genetic Technologies Limited's news releases, calls and decks from 2024, newest first.
RHY: RHY Acquires Genetype Genetic Risk Assessment Business
December 22, 2024
Notice of Delisting from Nasdaq and Failure to Satisfy a Continued Listing Rule or Standard Form 6 K
December 12, 2024
Response to ASX Query
November 29, 2024
Continuation of Suspension from Quotation
November 21, 2024
Appointment of Voluntary Administrators
November 20, 2024
Genetic Technologies Receives NASDAQ Notification Regarding Minimum Stockholders’ Equity Deficiency Form 6 K
October 28, 2024
Voluntary Suspension
October 20, 2024
Trading Halt
October 16, 2024
Security Class Suspension from Quotation GTGN
September 16, 2024
Entitlement Offer Results and Closing
September 11, 2024
GTG invited to join prestigious CancerIQ platform
September 11, 2024
FY24 results announcement and operations update
August 30, 2024
Preliminary Final Report
August 30, 2024
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
August 15, 2024
Global launch of geneType on EasyDNA platform
August 14, 2024
Entitlement Offer Prospectus
August 2, 2024
Strategic restructure to focus on USA sales growth
July 25, 2024
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
July 16, 2024
GeneType to Enter Canadian and New Zealand Markets
July 8, 2024
GeneType identifies 79.5% at risk of serious disease
June 25, 2024
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024
GTG Expands Operational Capacity in North America
June 17, 2024
GeneType and Stayhealthy Announce Landmark Distribution Agre
June 5, 2024
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024
Launch of test for 100% risk of breast and ovarian cancer
May 28, 2024
GTG and Wellworks for You sign B2B sales and marketing deal
May 6, 2024
Prospectus Supplement
April 22, 2024
GTG announces US$2 Million Registered Direct Offering
April 19, 2024
GTG Announces New Precision Oncology Tests
April 17, 2024
GTG to pilot GeneType in Breast Screen centres across the US
April 10, 2024
GTG to develop Worlds Most Advanced Comprehensive Risk Test
March 22, 2024
Appendix 4D & Half-year Financial Report - 31 December 2023
February 23, 2024
Appendix 4C & Quarterly Business Update December 2023
January 30, 2024